GSK plc
Source: SEC Form 13F · as of Mar 2026GSK plc holds 5 biotech & pharma companies tracked by BioSniper, totaling $83.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
5
Total value held
$83.7M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Lyell Immunopharma, Inc. (LYEL)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| LYELLyell Immunopharma, Inc. | 1,512,659 | $30.3M |
| CYTKCYTOKINETICS INC | 340,434 | $22.4M |
| SPROSpero Therapeutics, Inc. | 9,190,606 | $21.5M |
| BCYCBICYCLE THERAPEUTICS PLC | 1,529,561 | $7.1M |
| RGNXREGENXBIO Inc. | 271,456 | $2.3M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.